GCP
GSA Capital Partners Portfolio holdings
AUM
$1.43B
1-Year Return
20.34%
This Quarter Return
+10.17%
1 Year Return
+20.34%
3 Year Return
+63.52%
5 Year Return
+120%
10 Year Return
+237.47%
AUM
$858M
AUM Growth
+$119M
(+16%)
Cap. Flow
+$76.1M
Cap. Flow
% of AUM
8.86%
Top 10 Holdings %
Top 10 Hldgs %
5.44%
Holding
1,900
New
553
Increased
416
Reduced
412
Closed
513
Top Buys
| 1 |
Freeport-McMoran
FCX
|
+$4.93M |
| 2 |
Apple
AAPL
|
+$3.7M |
| 3 |
Frontline
FRO
|
+$3.64M |
| 4 |
NVIDIA
NVDA
|
+$3.36M |
| 5 |
SPDR S&P Regional Banking ETF
KRE
|
+$3.03M |
Top Sells
| 1 |
Spotify
SPOT
|
+$7.28M |
| 2 |
Willis Towers Watson
WTW
|
+$4.19M |
| 3 |
TD Synnex
SNX
|
+$2.78M |
| 4 |
Genpact
G
|
+$2.51M |
| 5 |
US Foods
USFD
|
+$2.42M |
Sector Composition
| 1 | Technology | 15.79% |
| 2 | Consumer Discretionary | 14.92% |
| 3 | Healthcare | 13.22% |
| 4 | Industrials | 11.95% |
| 5 | Financials | 11.6% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
MINI
976
DELISTED
Mobile Mini Inc
MINI
| $320K | 0.04% |
+8,431
| New | +$320K |
|
977
American Public Education
APEI
$639M
| $319K | 0.04% |
+11,655
| New | +$319K |
|
978
Medtronic
MDT
$121B
| $319K | 0.04% |
2,813
+413
| +17% | +$46.8K |
|
|
VRS
979
DELISTED
Verso Corporation
VRS
| $319K | 0.04% |
17,707
-8,125
| -31% | -$146K |
|
980
1-800-Flowers.com
FLWS
$334M
| $318K | 0.04% |
21,940
-78,235
| -78% | -$1.13M |
|
981
KNOT Offshore Partners
KNOP
$300M
| $318K | 0.04% |
16,030
-234
| -1% | -$4.64K |
|
982
Xylem
XYL
$34.5B
| $317K | 0.04% |
4,018
+334
| +9% | +$26.4K |
|
983
Dolby
DLB
$6.91B
| $316K | 0.04% |
+4,595
| New | +$316K |
|
984
Sterling Infrastructure
STRL
$9.63B
| $316K | 0.04% |
22,424
+8,226
| +58% | +$116K |
|
985
Compass Minerals
CMP
$771M
| $315K | 0.04% |
+5,175
| New | +$315K |
|
986
Eli Lilly
LLY
$678B
| $315K | 0.04% |
2,400
-2,332
| -49% | -$306K |
|
|
NVRO
987
DELISTED
NEVRO CORP.
NVRO
| $315K | 0.04% |
+2,684
| New | +$315K |
|
988
A.O. Smith
AOS
$10.4B
| $314K | 0.04% |
+6,582
| New | +$314K |
|
989
Corbus Pharmaceuticals
CRBP
$116M
| $314K | 0.04% |
1,916
+1,391
| +265% | +$228K |
|
|
PACW
990
DELISTED
PacWest Bancorp
PACW
| $314K | 0.04% |
8,217
-5,654
| -41% | -$216K |
|
991
Blue Bird Corp
BLBD
$1.85B
| $313K | 0.04% |
+13,651
| New | +$313K |
|
992
Delek US
DK
$1.72B
| $313K | 0.04% |
9,342
+3,377
| +57% | +$113K |
|
993
Leidos
LDOS
$23.8B
| $313K | 0.04% |
3,200
-7,556
| -70% | -$739K |
|
|
CHS
994
DELISTED
Chicos FAS, Inc.
CHS
| $313K | 0.04% |
82,142
-68,279
| -45% | -$260K |
|
995
Morgan Stanley
MS
$250B
| $312K | 0.04% |
+6,107
| New | +$312K |
|
996
Orthofix Medical
OFIX
$593M
| $312K | 0.04% |
6,754
-404
| -6% | -$18.7K |
|
997
Prestige Consumer Healthcare
PBH
$3.2B
| $312K | 0.04% |
7,700
-1,800
| -19% | -$72.9K |
|
998
SpartanNash
SPTN
$898M
| $312K | 0.04% |
21,900
-13,155
| -38% | -$187K |
|
999
WESCO International
WCC
$10.7B
| $312K | 0.04% |
+5,251
| New | +$312K |
|
1000
Church & Dwight Co
CHD
$23B
| $311K | 0.04% |
4,423
-10,650
| -71% | -$749K |
|